The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2407159121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Anne E van Vlimmeren und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Columbia University, New York, NY 10027. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 11, src Homology Domains, Molecular Dynamics Simulation. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, HHS | NIH | National Institute of General Medical Sciences (NIGMS), NSF | National Science Foundation Graduate Research Fellowship Program (GRFP).
Abstract (Originalsprache)
Mutations in the tyrosine phosphatase Src homology-2 domain-containing protein tyrosine phosphatase-2 (SHP2) are associated with a variety of human diseases. Most mutations in SHP2 increase its basal catalytic activity by disrupting autoinhibitory interactions between its phosphatase domain and N-terminal SH2 (phosphotyrosine recognition) domain. By contrast, some disease-associated mutations located in the ligand-binding pockets of the N- or C-terminal SH2 domains do not increase basal activity and likely exert their pathogenicity through alternative mechanisms. We lack a molecular understanding of how these SH2 mutations impact SHP2 structure, activity, and signaling. Here, we characterize five SHP2 SH2 domain ligand-binding pocket mutants through a combination of high-throughput biochemical screens, biophysical and biochemical measurements, and molecular dynamics simulations. We show that while some of these mutations alter binding affinity to phosphorylation sites, the T42A mutation in the N-SH2 domain is unique in that it also substantially alters ligand-binding specificity, despite being 8 to 10 Å from the specificity-determining region of the SH2 domain. This mutation exerts its effect on sequence specificity by remodeling the phosphotyrosine-binding pocket, altering the mode of engagement of both the phosphotyrosine and surrounding residues on the ligand. The functional consequence of this altered specificity is that the T42A mutant has biased sensitivity toward a subset of activating ligands and enhances downstream signaling. Our study highlights an example of a nuanced mechanism of action for a disease-associated mutation, characterized by a change in protein–protein interaction specificity that alters enzyme activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Columbia University, New York, NY 10027.
- Department of Biological Sciences, Columbia University, New York, NY 10027.
- Department of Biochemistry, Vanderbilt University, Nashville, TN 37232.
- Division of Microbiology and Immunology, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.
ORCID-Profile: Anne E van Vlimmeren, Deepti Karandur, Wan-Lin Lo, Neel H Shah
Förderung
- NIGMS NIH HHS
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- NSF | National Science Foundation Graduate Research Fellowship Program (GRFP)
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- Praespero (Praespero Foundation)
Zitieren
APA
van Vlimmeren, A. E., Voleti, R., Chartier, C. A., Jiang, Z., Karandur, D., Humphries, P. A., Lo, W. L., & Shah, N. H. (2024). The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2407159121
Vancouver
van Vlimmeren AE, Voleti R, Chartier CA, Jiang Z, Karandur D, Humphries PA, et al. The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2407159121
BibTeX
@article{vanVlimmeren2024,
author = {van Vlimmeren, Anne E and Voleti, Rashmi and Chartier, Cassandra A and Jiang, Ziyuan and Karandur, Deepti and Humphries, Preston A and Lo, Wan-Lin and Shah, Neel H},
title = {The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2407159121}
}
EUVIMED